Value of peri-procedural B-type natriuretic peptide levels in predicting cardiac events after elective percutaneous coronary intervention

Acta Cardiologica

Volumn 63, Issue 1, 2008, Pages 47-52

  Yildirir, Aylin ^a,b   Acikel, Sadik ^a   Ertan, Cagatay ^a   Aydinalp, Alp ^a   Ozin, Bulent ^a   Muderrisoglu, Haldun ^a  

^a BASKENT UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

B type natriuretic peptide; Chronic ischaemic heart disease; Percutaneous coronary intervention

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IOHEXOL; NITRIC ACID DERIVATIVE;

ANGINA PECTORIS; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; FOLLOW UP; HEART DEATH; HEART INFARCTION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; PROTEIN BLOOD LEVEL; REVASCULARIZATION;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY DISEASE; FEMALE; HEART DISEASES; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PROGNOSIS; STENTS;

EID: 39349092607     PISSN: 00015385     EISSN: None     Source Type: Journal    
DOI: 10.2143/AC.63.1.2025331     Document Type: Article

References (17)

1. Dao Q, Krishnaswamy P, Kazanegra R, Harrison A, Amirnovin R, Lenert L, Clopton P, Alberto J, Hlavin P, Maisel AS. Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting. J Am Coll Cardiol 2001; 37: 379-85.
2. de Lemos JA, Morrow DA, Bentley JH, Omland T, Sabatine MS, McCabe CH, Hall C, Cannon CP, Braunwald E. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 2001; 345: 1014-21.
3. Darbar D, Davidson NC, Gillespie N, Choy AM, Lang CC, Shyr Y, McNeill CP, Pringle TH, Struthers AD. Diagnostic value of B-type natriuretic peptide concentrations in patients with acute myocardial infarction. Am J Cardiol 1996; 78: 284-7.
4. Sutton TM, Stewart RA, Gerber IL, West TM, Richards AM, Yandle TG, Kerr AJ. Plasma natriuretic peptide levels increase with symptoms and severity of mitral regurgitation. J Am Coll Cardiol 2003; 41: 2280-7.
5. Crilley JG, Farrer M. Left ventricular remodelling and brain natriuretic peptide after first myocardial infraction. Heart 2001; 86: 638-42.
6. Arjomand H, Turi ZG, McCormick D, Goldberg S. Percutaneous coronary interventions: historical perspectives, current status, and future directions. Am Heart J 2003; 146: 787-96.
7. Ryan TJ, Faxon DP, Gunnar RM, Kennedy JW, King SB III, Loop FD, Peterson KL, Reeves TJ, Williams DO, Winters WL Jr. Guidelines for percutaneous coronary angioplasty: A report of the American Collage of Cardiology/American Heart Association Tast Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty). J Am Coll Cardiol 1988; 12: 529-45.
8. Crilley JG, Farrer M. Left ventricular remodelling and brain natriuretic peptide after first myocardial infraction. Heart 2001; 86: 638-42.
9. Toth M, Vuorinen KH, Vuolteenaho O, Hassinen IE, Uusimaa PA, Leppaluoto J, Ruskoaho H. Hypoxia stimulates release of ANP and BNP from perfused rat ventricular myocardium. Am J Physiol 1994; 266: H1572-80.
10. Goetze JP, Christoffersen C, Perko M, Arendrup H, Rehfeld JF, Kastrup J, Nielsen LB. Increased cardiac BNP expression associated with myocardial ischemia. FASEB J 2003; 17: 1105-7.
11. Kragelund C, Gronning B, Kober L, Hildebrandt P, Steffensen R. N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease. N Engl J Med 2005; 352: 666-75.
12. Omland T, Richards M, Wergeland R, Vik-Mo H. B-type natriuretic peptide and long-term survival in patients with stable coronary artery disease. Am J Cardiol 2005; 95: 24-8.
13. Ndrepepa G, Braun S, Niemöller K, Mehilli J, von Beckerath N, von Beckerath O, Vogt W, Schomig A, Kastrati A. Prognostic value of N-terminal pro-brain natriuretic peptide in patients with chronic stable angina. Circulation 2005; 112: 2102-7.
14. Schnabel R, Lubos E, Rupprecht HJ, Espinola-Klein C, Bickel C, Lackner KJ, Cambien F, Tiret L, Munzel T, Blankenberg S. B-type natriuretic peptide and the risk of cardiovascular events and death in patients with stable angina. J Am Coll Cardiol 2006; 47: 552-8.
15. de Winter R, Stroobants A, Koch K, Bax M, Schotborgh C, Mulder K, Sanders G, van Straalen J, Fischer J, Tijssen J, Piek J. Plasma N-terminal pro-B-type natriuretic peptide for prediction of death or nonfatal myocardial infarction following percutaneous coronary intervention. Am J Cardiol 2004; 94: 1481-5.
16. Saleh N, Braunschweig F, Jensen J, Tornvall P. Usefulness of preprocedural serum N-terminal pro-brain natriuretic peptide levels to predict long-term outcome after percutaneous coronary intervention in patients with normal troponin T levels. Am J Cardiol 2006; 97: 830-4.
17. Kyriakides ZS, Markianos M, Michalis L, Antoniadis A, Nikolaou NI, Kremastinos DT. Brain natriuretic peptide increases acutely and much more prominently than atrial natriuretic peptide during coronary angioplasty. Clin Cardiol 2000; 23: 285-8.